azimexon has been researched along with leucine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hoffman, FA; Kishter, S; Pizzo, PA | 1 |
| Eichelberg, D; Schmutzler, W | 1 |
| Hadden, JW | 1 |
| Wybran, J | 1 |
| Mathé, G; Reizenstein, P | 1 |
| Mathe, G | 1 |
| Bruley-Rosset, M; Florentin, I; Goutner, A; Mathé, G; Serrou, B | 1 |
3 review(s) available for azimexon and leucine
| Article | Year |
|---|---|
[Pharmacological aspects of immunostimulants].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Bordetella pertussis; Clinical Trials as Topic; Cord Factors; Freund's Adjuvant; Glycolipids; Humans; Hypoxanthines; Immunochemistry; Inosine Pranobex; Leucine; Levamisole; Lipopolysaccharides; Mycobacterium bovis; Picibanil; Polynucleotides; Polysaccharides; Propionibacterium | 1983 |
Biological response modifiers and differentiation inducers. Current status in cancer research.
Topics: Adjuvants, Immunologic; Aziridines; Bacterial Vaccines; Cell Differentiation; Cyclosporins; Dimethyl Sulfoxide; Glucans; Hormones; Humans; Leucine; Levamisole; Lithium; Neoplasms; Peptides; Retinoids; Selenium | 1983 |
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
1 trial(s) available for azimexon and leucine
| Article | Year |
|---|---|
[Pharmacological aspects of immunostimulants].
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Bordetella pertussis; Clinical Trials as Topic; Cord Factors; Freund's Adjuvant; Glycolipids; Humans; Hypoxanthines; Immunochemistry; Inosine Pranobex; Leucine; Levamisole; Lipopolysaccharides; Mycobacterium bovis; Picibanil; Polynucleotides; Polysaccharides; Propionibacterium | 1983 |
4 other study(ies) available for azimexon and leucine
| Article | Year |
|---|---|
Production of and response to interleukin-2 by cultured T cells: effects of lithium chloride and other putative modulators.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Aziridines; Cell Line; Chlorides; Humans; Interleukin-2; Leucine; Lithium; Lithium Chloride; Phytohemagglutinins; T-Lymphocytes | 1985 |
Chemically defined immunotherapeutic agents.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Benzimidazoles; Cimetidine; Ditiocarb; Humans; Hypoxanthines; Inosine Pranobex; Leucine; Levamisole; Mice; Neoplasms; Pyran Copolymer; Tuftsin | 1983 |
The immunopharmacology of synthetic immunomodulators.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adjuvants, Immunologic; Animals; Aziridines; Ditiocarb; Glucans; Humans; Hypoxanthines; Immunity; Inosine Pranobex; Interferon Inducers; Leucine; Levamisole; Lynestrenol; Neoplasms | 1983 |
Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Topics: Adjuvants, Immunologic; Animals; Aziridines; Azirines; Cytotoxicity, Immunologic; Drug Evaluation, Preclinical; Immunoglobulin Fragments; Immunotherapy; Leucine; Mice; Neoplasms, Experimental; T-Lymphocytes; Tuftsin | 1982 |